Not available outside of the UK & Ireland.
Application
Isradipine has been used to explore neuroprotective activity.
Biochem/physiol Actions
L-type calcium channel blocker (also referred to as dihydropyridine-type calcium channel blocker); antihypertensive.
Isradipineis considered as an active calcium channel blocker, used to treat hypertension.
Features and Benefits
This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Other Notes
Tandem Mass Spectrometry data independently generated by Scripps Center for Metabolomics is available to view or download in PDF. I6658.pdf Tested metabolites are featured on Scripps Center for Metabolomics METLIN Metabolite Database. To learn more, visit sigma.com/metlin.
Packaging
5, 25 mg in glass bottle
This product has met the following criteria to qualify for the following awards: